AGEN three-lens brief
Evidence-based stock research on AGEN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.85% yesterday. · Underperforming SPY by 26.9pp over 30 days.
- Moved +2.85% yesterday.
- Underperforming SPY by 26.9pp over 30 days.
- Analyst mean target $27.00 — 274% above current (3 analysts).
- Negative free cash flow last quarterly (-$920.0K).
- Reported earnings on 2026-11-05.
AGEN closed at $7.22 (+2.85%) as of 2026-11-12. Market cap: $326.68M. P/E (trailing) 31.4. Price is below the 50-day MA and above the 200-day MA. Positives: moved +2.85% yesterday.; analyst mean target $27.00 — 274% above current (3 analysts).. Concerns: underperforming SPY by 26.9pp over 30 days.; negative free cash flow last quarterly (-$920.0K).. Last quarter: Revenue $31.50M, net income $1.52M, free cash flow -$920.0K.
Why three lenses on AGEN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGEN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AGEN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGEN brief"></iframe>